NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Diabetes Pathogenesis



RAS and NOS3 polymorphisms do not seem to influence cardiovascular disease in diabetics



April 10th, 2006

RAS and NOS3 polymorphisms do not appear to strongly influence subclinical cardiovascular disease or blood pressure in this diabetic population.

"Cardiovascular disease (CVD) is a major complication of type 2 diabetes mellitus. The renin-angiotensin system (RAS) and nitric oxide production are both important regulators of vascular function and blood pressure. Genes encoding proteins involved in these pathways are candidates for a contribution to CVD in diabetic patients," investigators in the United States report.

K.P. Burdon and colleagues at Wake Forest University examined "variants of the angiotensinogen (AGT), angiotensin converting enzyme (ACE),...


Source: Diabetes Week (2006-04-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login